β¨ Medicine Distribution Consents
NEW ZEALAND GAZETTE, No. 34 β 2 APRIL 2015
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Actemra
Active Ingredient: Tocilizumab 162mg
Dosage Form: Solution for injection
New Zealand Sponsor: Roche Products (NZ) Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
Product: Apo-Sumatriptan (Prescription)
Active Ingredient: Sumatriptan succinate 70.08mg equivalent to Sumatriptan 50mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Ipca Pharma (NZ) Pty Limited
Manufacturer: Ipca Laboratories Limited, Dadra and Nagar Haveli, India
Product: Apo-Sumatriptan (Restricted)
Active Ingredient: Sumatriptan succinate 70.08mg equivalent to Sumatriptan 50mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Ipca Pharma (NZ) Pty Limited
Manufacturer: Ipca Laboratories Limited, Dadra and Nagar Haveli, India
Product: Apo-Sumatriptan
Active Ingredient: Sumatriptan succinate 140.15mg equivalent to Sumatriptan 100mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Ipca Pharma (NZ) Pty Limited
Manufacturer: Ipca Laboratories Limited, Dadra and Nagar Haveli, India
Product: Ipca-Sumatriptan
Active Ingredient: Sumatriptan succinate 70.08mg equivalent to Sumatriptan 50mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Ipca Pharma (NZ) Pty Limited
Manufacturer: Ipca Laboratories Limited, Dadra and Nagar Haveli, India
Product: Ipca-Sumatriptan
Active Ingredient: Sumatriptan succinate 140.15mg equivalent to Sumatriptan 100mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Ipca Pharma (NZ) Pty Limited
Manufacturer: Ipca Laboratories Limited, Dadra and Nagar Haveli, India
Product: Valganciclovir Mylan
Active Ingredient: Valganciclovir hydrochloride 496.3mg equivalent to Valganciclovir 450mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Mylan Laboratories Limited, Maharashtra State India
Dated this 27th day of March 2015.
SARAH READER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2015-go1855
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and set out in the Schedule hereto:
Schedule
41
Next Page →
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare27 March 2015
Medicines, Distribution, Consent, Medicines Act 1981, New Zealand Sponsor
- SARAH READER, Acting Group Manager, Medsafe, Ministry of Health
π₯
Consent to the Distribution of New Medicines
(continued from previous page)
π₯ Health & Social WelfareMedicines, Distribution, Consent, Medicines Act 1981, New Zealand Sponsor
NZ Gazette 2015, No 34